← Back to Search

Other

AIV007 Treatment Dose 3 for Age-Related Macular Degeneration

Phase 1
Waitlist Available
Research Sponsored by AiViva BioPharma, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 224 days
Awards & highlights

Summary

This trial is testing a special gel injected into the eye for patients with a severe eye condition called neovascular age-related macular degeneration. The gel releases medicine slowly to help manage the disease.

Eligible Conditions
  • Age-Related Macular Degeneration

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 224 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 224 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Events
Secondary outcome measures
Mean change from baseline in BCVA
Mean change from baseline in central subfield thickness as measured by optical coherence tomography
Mean time to escape medication

Trial Design

3Treatment groups
Experimental Treatment
Group I: AIV007 Treatment Dose 3Experimental Treatment1 Intervention
Intravitreal, Dose 3
Group II: AIV007 Treatment Dose 2Experimental Treatment1 Intervention
Intravitreal, Dose 2
Group III: AIV007 Treatment Dose 1Experimental Treatment1 Intervention
Intravitreal, Dose 1
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
AIV007
2020
Completed Phase 1
~10

Find a Location

Who is running the clinical trial?

AiViva BioPharma, Inc.Lead Sponsor
5 Previous Clinical Trials
97 Total Patients Enrolled
~1 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top